Israeli Pharmaceutical Giant Teva Mulls Halting Development of Brand Drugs

Jeremy Levin, the incoming chief executive of Teva Pharmaceutical Industries, has set up a team to reexamine the company’s pipeline of brand drugs under development.
Ha’aretz